Drug Trial Radar · NCT01542034
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Last checked: Nov 19, 2026Latest source record: Jun 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
506
Actual
Start
Feb 2012
Primary completion
May 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Kythera BiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 1, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
Conditions
- Moderate or Severe Submental Fullness
Interventions
Deoxycholic acid injectionDrug
Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.
PlaceboDrug
Phosphate buffered saline placebo for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved a Composite 1-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
- Percentage of Participants Who Achieved a Composite 2-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
Locations
36 sites in 2 countries. Site status is shown where the registry gives one.
Investigational Site
Birmingham, Alabama
Investigational Site
Beverly Hills, California
Investigational Site
Beverly Hills, California
Investigational Site
Irvine, California
Investigational Site
Los Angeles, California
Investigational Site
Oceanside, California
Investigational Site
San Diego, California
Investigational Site
San Diego, California
Investigational Site
New Haven, Connecticut
Investigational Site
Washington D.C., District of Columbia
Investigational Site
Miami Beach, Florida
Investigational Site
West Palm Beach, Florida
Investigational Site
Atlanta, Georgia
Investigational Site
Snellville, Georgia
Investigational Site
Arlington, Illinois
Investigational Site
Chicago, Illinois
Investigational Site
Evansville, Indiana
Investigational Site
Louisville, Kentucky
Investigational Site
Glenn Dale, Maryland
Investigational Site
Hunt Valley, Maryland
Investigational Site
Rockville, Maryland
Investigational Site
West Bloomfield, Michigan
Investigational Site
Fridley, Minnesota
Investigational Site
Omaha, Nebraska
Investigational Site
New York, New York
Investigational Site
New York, New York
Investigational Site
Charlotte, North Carolina
Investigational Site
Nashville, Tennessee
Investigational Site
Nashville, Tennessee
Investigational Site
Charlottesville, Virginia
Investigational Site
Spokane, Washington
Investigational Site
Vancouver, B.C., Canada
Investigational Site
Peterborough, Ontario, Canada
Investigational Site
Toronto, Ontario, Canada
Investigational Site
Toronto, Ontario, Canada
Investigational Site
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.